Equities

Lifecare ASA

Lifecare ASA

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (NOK)2.48
  • Today's Change0.38 / 18.10%
  • Shares traded1.17m
  • 1 Year change+53.57%
  • Beta--
Data delayed at least 15 minutes, as of Jun 14 2024.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Lifecare ASA is a Norway-based company that develops miniaturized and implantable nanobiosensors for correct and continuous monitoring of glucose and other biomarkers. Lifecare's activities are concentrated on the development of sensor for use as a medical product, initially the sensor Sencell for continuous monitoring of glucose (blood sugar) for people with diabetes. The technology is suitable for detecting and measuring a wide range of molecules that can occur in the human body, based on variations in osmotic pressure.

  • Revenue in NOK (TTM)13.09m
  • Net income in NOK-35.26m
  • Incorporated2006
  • Employees32.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Ascelia Pharma AB0.00-90.13m316.40m13.00--5.12-----2.63-2.630.001.800.00----0.00-65.17---78.39--------------0.2302------16.72------
Bactiquant A/S18.84m-20.06m350.79m----15.90--18.62-0.6358-0.63580.59710.61330.50553.672.83---53.83-41.26-62.59-47.16-6.1412.89-106.51-71.775.43-8.540.0431---0.689--7.62------
Medivir AB7.85m-98.01m353.87m10.00--1.65--45.06-1.46-1.460.10281.890.032--1.56773,300.00-40.00-28.91-47.20-34.77-888.81-467.42-1,248.18-675.96----0.0482--73.16-20.39-0.6275---47.96--
INIFY Laboratories AB3.47m-52.22m358.58m23.00--4.83--103.21-1.15-1.150.07681.640.0322.990.6608---48.10---48.10--76.42---1,503.10------0.00--------------
Magle Chemoswed Holding AB172.64m12.42m366.29m78.0029.502.2314.402.121.131.1315.7414.950.60680.4938.302,179,628.004.362.525.863.5290.5885.677.193.920.63566.350.3081--17.009.9733.07---6.34--
Herantis Pharma Oyj0.003.20m382.28m10.00132.067.08119.59--0.01260.01260.000.23440.00----0.004.31-80.466.16-104.37------------0.0073------103.00------
Lytix Biopharma AS3.99m-87.90m392.91m10.00--6.28--98.45-2.16-2.160.09811.260.0368--0.4091399,100.00-80.96-56.91-94.07-65.83-----2,202.36-771.78----0.0095---63.8263.94-56.77------
Saniona AB21.03m-84.59m439.40m23.00--15.87--20.89-1.09-1.090.26290.24510.1726--5.63900,521.80-69.41-59.16-127.89-70.15-136.88-970.05-402.20-1,483.55---3.850.71--10.19-21.0554.71---34.94--
Xbrane Biopharma AB193.92m-366.85m448.07m75.00--1.12--2.31-1.33-1.580.69780.25770.24651.34332.122,053,430.00-46.63-40.98-78.01-67.2415.43---189.18-364.401.43-31.130.3693--314.3363.42-91.10--60.02--
Bergenbio ASA521.00k-154.52m452.39m16.00--333.46--868.32-0.1849-0.18490.00030.03470.0047--0.048520,840.00-139.81-66.15-275.19-78.74-----29,658.54-11,419.44----0.00---9.00-31.4336.98------
Enzymatica AB (publ)48.02m-54.50m478.88m18.00--5.62--9.97-0.3247-0.32470.28660.48410.32691.386.48---37.11-27.36-39.16-33.9864.2565.08-113.50-66.12---23.260.2502--4.00-0.638227.57--7.02--
Mendus AB (publ)0.00-108.72m479.67m28.00--0.6023-----3.15-3.150.0015.570.00----0.00-16.09-18.84-17.35-20.21-------28,474.53----0.0348---100.00--26.78------
Lifecare ASA13.09m-35.26m480.88m32.00--5.96--36.75-0.2454-0.24540.0920.41630.1621--4.90408,943.10-43.60-40.00-49.97-45.26-----269.03-175.53----0.1812---40.8830.29-101.74------
Hamlet BioPharma AB0.00-33.92m529.33m7.00--9.01-----0.2326-0.23260.000.4530.00-------63.45-83.52-69.09-107.84------------0.00-------18.87--78.01--
Initiator Pharma A/S0.00-34.51m547.97m3.00--16.01-----0.6241-0.62410.000.63690.00----0.00-70.60-68.27-73.77-74.02------------0.00------27.95------
Data as of Jun 14 2024. Currency figures normalised to Lifecare ASA's reporting currency: Norwegian Krone NOK

Institutional shareholders

5.34%Per cent of shares held by top holders
HolderShares% Held
Nordea Investment Management AB (Norway)as of 12 Feb 202410.36m5.34%
Data from 30 Apr 2024 - 30 Apr 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.